These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 621391)

  • 21. Motility of human polymorphonuclear leukocytes. Roles of hydroxy fatty acids, other lipids, and cations.
    Lynn WS; Mukherjee C
    Am J Pathol; 1978 Jun; 91(3):581-94. PubMed ID: 655264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of the cardiovascular actions of prostaglandins by thromboxane B2.
    Kot PA; Rose JC; Ramwell PW; Fitzpatrick TM; Bloom MR; Friedman LS
    Adv Prostaglandin Thromboxane Res; 1980; 7():679-82. PubMed ID: 7369035
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of prostaglandin precursors, prostaglandins, and prostaglandin metabolites on pulmonary circulation of perinatal goats.
    Tyler TL; Leffler CW; Cassin S
    Chest; 1977 Feb; 71(2 suppl):271-3. PubMed ID: 836369
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunologic release in the rat peritoneal cavity lipid chemotactic and chemokinetic factors for polymorphonuclear leukocytes.
    Valone FH; Goetzl EJ
    J Immunol; 1978 Jan; 120(1):102-8. PubMed ID: 304864
    [No Abstract]   [Full Text] [Related]  

  • 25. Action of unsaturated fatty acids and prostaglandins on parameters of excitation and contraction in the guinea pig myocardium.
    Mentz P; Opitz H; Förster W
    Acta Biol Med Ger; 1976; 35(8-9):1165-6. PubMed ID: 1007767
    [No Abstract]   [Full Text] [Related]  

  • 26. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unsaturated fatty acids and lipoxygenase products regulate phagocytic NADPH oxidase activity by a nondetergent mechanism.
    Corey SJ; Rosoff PM
    J Lab Clin Med; 1991 Oct; 118(4):343-51. PubMed ID: 1940576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of arachidonic acid metabolites and steroids on function of bovine polymorphonuclear neutrophils.
    Hoedemaker M; Lund LA; Wagner WC
    Am J Vet Res; 1992 Sep; 53(9):1534-9. PubMed ID: 1329587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins.
    Garfield RE; Kannan MS; Daniel EE
    Am J Physiol; 1980 Mar; 238(3):C81-9. PubMed ID: 7369350
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prostoglandins and thromboxans in the regulation of bronchial function].
    Szczeklik A; Nizankowska E
    Pol Tyg Lek; 1977 Aug; 32(35):1371-3. PubMed ID: 331287
    [No Abstract]   [Full Text] [Related]  

  • 31. Actions of prostaglandin precursors and other unsaturated fatty acids on conduction time and refractory period in the cat heart in situ.
    Bayer BL; Förster W
    Acta Biol Med Ger; 1978; 37(5-6):833-5. PubMed ID: 742298
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotactic activity of thromboxane B2, prostaglandins and their metabolites for polymorphonuclear leucocytes.
    Kitchen EA; Boot JR; Dawson W
    Prostaglandins; 1978 Aug; 16(2):239-44. PubMed ID: 704931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).
    Goetzl EJ; Pickett WC
    J Immunol; 1980 Oct; 125(4):1789-91. PubMed ID: 7410854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil migration inhibitory properties of polyunsaturated fatty acids. The role of fatty acid structure, metabolism, and possible second messenger systems.
    Ferrante A; Goh D; Harvey DP; Robinson BS; Hii CS; Bates EJ; Hardy SJ; Johnson DW; Poulos A
    J Clin Invest; 1994 Mar; 93(3):1063-70. PubMed ID: 8132744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil and eosinophil chemotaxins in asthma.
    Teran LM; Montefort S; Douglass J; Holgate ST
    Q J Med; 1993 Dec; 86(12):761-9. PubMed ID: 8108534
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostaglandins and chemotaxis: enhancement of polymorphonuclear leukocyte chemotaxis by prostaglandin F2alpha.
    Diaz-Perez JL; Goldyne ME; Winkelmann RK
    J Invest Dermatol; 1976 Mar; 66(3):149-52. PubMed ID: 1249443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid.
    Goetzl EJ; Wasserman SI; Gigli I; Austen KF
    J Clin Invest; 1974 Mar; 53(3):813-8. PubMed ID: 4273024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo chemotaxis induced by polyunsaturated fatty acids.
    Penneys NS; Simon P; Ziboh VA; Schlossberg J
    J Invest Dermatol; 1977 Nov; 69(5):435-8. PubMed ID: 409781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the eosinophil chemotactic factor (ECF) release from human PMNs and rat mast cells by arachidonic acid analogs.
    Kroegel C; Kunau HW; König W
    Cell Immunol; 1981 May; 60(2):480-8. PubMed ID: 7237570
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure of prostaglandins, prostaglandin metabolites and arachidonic acid to elicit chemotaxis of human polymorphonuclear leukocytes.
    Pazzaglia A; Barker A; Warin AP; Greaves MW
    Br J Dermatol; 1977 May; 96(5):533-6. PubMed ID: 871389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.